1. Home
  2. EVH vs STOK Comparison

EVH vs STOK Comparison

Compare EVH & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVH
  • STOK
  • Stock Information
  • Founded
  • EVH 2011
  • STOK 2014
  • Country
  • EVH United States
  • STOK United States
  • Employees
  • EVH N/A
  • STOK N/A
  • Industry
  • EVH Other Consumer Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVH Consumer Discretionary
  • STOK Health Care
  • Exchange
  • EVH Nasdaq
  • STOK Nasdaq
  • Market Cap
  • EVH 1.1B
  • STOK 1.1B
  • IPO Year
  • EVH 2015
  • STOK 2019
  • Fundamental
  • Price
  • EVH $8.60
  • STOK $23.40
  • Analyst Decision
  • EVH Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • EVH 15
  • STOK 6
  • Target Price
  • EVH $17.27
  • STOK $26.60
  • AVG Volume (30 Days)
  • EVH 3.1M
  • STOK 918.9K
  • Earning Date
  • EVH 11-06-2025
  • STOK 11-04-2025
  • Dividend Yield
  • EVH N/A
  • STOK N/A
  • EPS Growth
  • EVH N/A
  • STOK N/A
  • EPS
  • EVH N/A
  • STOK 0.91
  • Revenue
  • EVH $2,195,920,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • EVH N/A
  • STOK $415.58
  • Revenue Next Year
  • EVH $25.04
  • STOK N/A
  • P/E Ratio
  • EVH N/A
  • STOK $25.86
  • Revenue Growth
  • EVH N/A
  • STOK 1218.82
  • 52 Week Low
  • EVH $7.06
  • STOK $5.35
  • 52 Week High
  • EVH $31.80
  • STOK $24.60
  • Technical
  • Relative Strength Index (RSI)
  • EVH 37.82
  • STOK 81.74
  • Support Level
  • EVH $9.28
  • STOK $18.80
  • Resistance Level
  • EVH $10.08
  • STOK $24.60
  • Average True Range (ATR)
  • EVH 0.47
  • STOK 1.28
  • MACD
  • EVH -0.06
  • STOK 0.18
  • Stochastic Oscillator
  • EVH 5.13
  • STOK 81.82

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: